Hyperfine, Inc. (HYPR)

NASDAQ: HYPR · Real-Time Price · USD
1.420
+0.070 (5.19%)
At close: Sep 12, 2025, 4:00 PM EDT
1.390
-0.030 (-2.11%)
After-hours: Sep 12, 2025, 6:58 PM EDT
5.19%
Market Cap111.59M
Revenue (ttm)10.80M
Net Income (ttm)-39.36M
Shares Out 78.58M
EPS (ttm)-0.53
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume610,354
Open1.370
Previous Close1.350
Day's Range1.370 - 1.470
52-Week Range0.533 - 1.900
Beta1.07
AnalystsStrong Buy
Price Target1.28 (-9.86%)
Earnings DateNov 11, 2025

About HYPR

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredi... [Read more]

Sector Healthcare
Founded 2014
Employees 111
Stock Exchange NASDAQ
Ticker Symbol HYPR
Full Company Profile

Financial Performance

In 2024, Hyperfine's revenue was $12.89 million, an increase of 16.84% compared to the previous year's $11.03 million. Losses were -$40.72 million, -7.95% less than in 2023.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for HYPR stock is "Strong Buy." The 12-month stock price target is $1.28, which is a decrease of -9.86% from the latest price.

Price Target
$1.28
(-9.86% downside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces it has received CE Marking and UK Conformity Assessment (UKCA) approval for its Optive AI™ software.

10 days ago - Business Wire

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic ...

18 days ago - Business Wire

Hyperfine, Inc. (HYPR) Q2 2025 Earnings Call Transcript

Hyperfine, Inc. (NASDAQ:HYPR) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Brett Hale - Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Co...

4 weeks ago - Seeking Alpha

Hyperfine, Inc. Reports Second Quarter 2025 Financial Results

GUILFORD, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered p...

4 weeks ago - GlobeNewsWire

Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine hits 100-patient milestone in portable MRI study, accelerating access to brain imaging in neurology clinics with next-gen Swoop® system.

5 weeks ago - Business Wire

Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments

GUILFORD, Conn.--(BUSINESS WIRE)--First patients enrolled in PRIME study at Yale School of Medicine, aiming to evaluate the potential of AI-powered portable MRI tech in the ED setting.

6 weeks ago - Business Wire

Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI syste...

6 weeks ago - Business Wire

Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer's Association International Conference

TORONTO--(BUSINESS WIRE)--Swoop® AI-powered portable MRI system shows 100% sensitivity for ARIA-E detection in Lecanemab patients (CARE PMR study data presented at AAIC 2025).

6 weeks ago - Business Wire

Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care

GUILFORD, Conn.--(BUSINESS WIRE)--New studies showcase the Swoop® MRI system's potential role in expanding access to dementia care and monitoring Alzheimer's treatment.

7 weeks ago - Business Wire

Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine begins commercial launch of Optive AI™ software, bringing substantial image quality improvements to Swoop® systems.

7 weeks ago - Business Wire

Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces first sales of next-gen Swoop® MRI system, powered by Optive AI™ software, to top U.S. hospitals following FDA clearance.

2 months ago - Business Wire

Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine appoints Rob Fasciano, PhD, and Rafael O'Halloran, PhD, to help advance AI-powered MRI technology and scale next-gen imaging solutions.

3 months ago - Business Wire

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality

GUILFORD, Conn.--(BUSINESS WIRE)--FDA clears next-gen Swoop® MRI system with Optive AI™ software, bringing a transformative leap in image quality with enhanced usability and comfort.

3 months ago - Business Wire

Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first FDA-cleared AI-powered portable M...

3 months ago - Business Wire

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic ...

4 months ago - Business Wire

Hyperfine, Inc. (HYPR) Q1 2025 Earnings Call Transcript

Hyperfine, Inc. (NASDAQ:HYPR) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Maria Sainz - President and Chief Executive Officer Bret...

4 months ago - Seeking Alpha

Hyperfine, Inc. Reports First Quarter 2025 Financial Results

GUILFORD, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered po...

4 months ago - GlobeNewsWire

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (...

4 months ago - Business Wire

Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices

GUILFORD, Conn.--(BUSINESS WIRE)--Study examines clinical utility and patient experience of AI-powered portable MRI in neurology offices.

5 months ago - Business Wire

Hyperfine, Inc. (HYPR) Q4 2024 Earnings Call Transcript

Hyperfine, Inc. (NASDAQ:HYPR) Q4 2024 Results Conference Call March 17, 2025 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and Chief Executive Officer Brett H...

6 months ago - Seeking Alpha

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered ...

6 months ago - GlobeNewsWire

Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable

Hyperfine, Inc. HYPR shares are surging on Monday. Hyperfine collaborates with Nvidia to advance portable MRI technology. The partnership aims to improve image quality and reduce scan times.

Other symbols: NVDA
6 months ago - Benzinga

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. will report financial results for the fourth quarter and full year 2024 on Monday, March 17, 2025.

6 months ago - Business Wire

Hyperfine Announces $6.0 Million Registered Direct Offering

GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and...

7 months ago - Business Wire

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR #aipowered--Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for stroke diagnosis.

7 months ago - Business Wire